This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Juretschko, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Juretschko, S.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, April 2007, p. 1339-1342, Vol. 45, No. 4
0095-1137/07/$08.00+0     doi:10.1128/JCM.01716-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Accuracies of ß-Lactam Susceptibility Test Results for Pseudomonas aeruginosa with Four Automated Systems (BD Phoenix, MicroScan WalkAway, Vitek, and Vitek 2){triangledown}

Stefan Juretschko,1* Vincent J. LaBombardi,2 Stephen A. Lerner,3 Paul C. Schreckenberger,4 and and the Pseudomonas AST Study Group{dagger}

Arkansas Children's Hospital, Little Rock, Arkansas 72202,1 St. Vincent's Hospital-Manhattan, New York, New York 10011,2 Wayne State University, Detroit Medical Center, Detroit, Michigan 48201,3 Loyola University Medical Center, Maywood, Illinois 601534

Received 18 August 2006/ Returned for modification 7 November 2006/ Accepted 5 January 2007

Contemporary clinical isolates and challenge strains of Pseudomonas aeruginosa were tested by four automated susceptibility testing systems (BD Phoenix, MicroScan WalkAway, Vitek, and Vitek 2; two laboratories with each) against six broad-spectrum ß-lactams, and the results were compared to reference broth microdilution (BMD) and to consensus results from three validated methods (BMD, Etest [AB Biodisk, Solna, Sweden], and disk diffusion). Unacceptable levels of error (minor, major, and very major) were detected, some with systematic biases toward false susceptibility (piperacillin-tazobactam and imipenem) and others toward false resistance (aztreonam, cefepime, and ceftazidime). We encourage corrective action by the system manufacturers to address test biases, and we suggest that clinical laboratories using automated systems should consider accurate alternative methods for routine use.

* Corresponding author. Mailing address: Arkansas Children's Hospital, 800 Marshall Street, Little Rock, AR 72202. Phone: (501) 364-4246. Fax: (501) 364-3155. E-mail: JuretschkoSM{at}archildrens.org

{triangledown} Published ahead of print on 17 January 2007.

{dagger} The study group includes J. E. McGowan, Jr., F. C. Tenover, and P. P. Williams at Emory University and the Centers for Disease Control and Prevention, Atlanta, GA; G. Pipia at St. Vincent's Hospital-Manhattan, New York, NY; V. Rekasius at Loyola University Medical Center, Maywood, IL; C. E. Essmyer and J. Yates at St. Luke's Regional Laboratories, Kansas City, MO; T. Beavers-May at Arkansas Children's Hospital, Little Rock, AR; T. Painter at Wayne State University Detroit Medical Center, Detroit, MI; L. L. Steed and J. A. Bosso at Medical University of South Carolina, Charleston, SC; and R. N. Jones at JMI Laboratories, North Liberty, IA.

Journal of Clinical Microbiology, April 2007, p. 1339-1342, Vol. 45, No. 4
0095-1137/07/$08.00+0     doi:10.1128/JCM.01716-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Gordon, N. C., Wareham, D. W. (2009). Failure of the MicroScan WalkAway System To Detect Heteroresistance to Carbapenems in a Patient with Enterobacter aerogenes Bacteremia. J. Clin. Microbiol. 47: 3024-3025 [Abstract] [Full Text]  
  • Pena, C., Suarez, C., Tubau, F., Juan, C., Moya, B., Dominguez, M. A., Oliver, A., Pujol, M., Ariza, J. (2009). Nosocomial Outbreak of a Non-Cefepime-Susceptible Ceftazidime-Susceptible Pseudomonas aeruginosa Strain Overexpressing MexXY-OprM and Producing an Integron-Borne PSE-1 ss-Lactamase. J. Clin. Microbiol. 47: 2381-2387 [Abstract] [Full Text]  
  • Torres, E., Villanueva, R., Bou, G. (2009). Comparison of different methods of determining {beta}-lactam susceptibility in clinical strains of Pseudomonas aeruginosa. J Med Microbiol 58: 625-629 [Abstract] [Full Text]  
  • Eiland, E. H. III, Dunne, C. R., Lindgren, W. (2008). Pitfalls Associated With Antibiograms. Journal of Pharmacy Practice 21: 319-323 [Abstract]  
  • Mazzariol, A., Aldegheri, M., Ligozzi, M., Lo Cascio, G., Koncan, R., Fontana, R. (2008). Performance of Vitek 2 in Antimicrobial Susceptibility Testing of Pseudomonas aeruginosa Isolates with Different Mechanisms of {beta}-Lactam Resistance. J. Clin. Microbiol. 46: 2095-2098 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»